International Prognostic Modeling: A Platform for Collaborative Approach for Patients With Mesothelioma von Medina, Cristian G, Xu, Yuan, Ripley, R Taylor

Volltext

Commentary: KRAS-mutant lung adenocarcinomas—a work in progress von Corsini, Erin M., Ripley, R. Taylor

Volltext

Bile acid-induced “Minority MOMP” promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1 von Xu, Yuan, Surman, Deborah R., Diggs, Laurence, Xi, Sichuan, Gao, Shaojian, Gurusamy, Devikala, McLoughlin, Kaitlin, Drake, Justin, Feingold, Paul, Brown, Kate, Wangsa, Danny, Wangsa, Darawalee, Zhang, Xi, Ried, Thomas, Davis, Jeremy L., Hernandez, Jonathan, Hoang, Chuong D., Souza, Rhonda F., Schrump, David S., Taylor Ripley, R.

Volltext

MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis von Singh, Anand, Bhattacharyya, Nisan, Srivastava, Abhishek, Pruett, Nathanael, Ripley, R. Taylor, Schrump, David S., Hoang, Chuong D.

Volltext

Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy von KEMP, Clinton D, RAO, Mahadev, ZHU, Yuelin J, TAYLOR RIPLEY, R, MATHUR, Aarti, FANG LIU, MAOCHENG YANG, MELTZER, Paul A, MARQUEZ, Victor E, DE RIENZO, Assunta, BUENO, Raphael, SCHRUMP, David S, SICHUAN XI, INCHAUSTE, Suzanne, MANI, Haresh, FETSCH, Patricia, FILIE, Armando, MARY ZHANG, HONG, Julie A, WALKER, Robert L

Volltext

Finding a needle in a haystack of needles: The difficulty of defining a consistently meaningful cytokine signature von McLoughlin, Kaitlin C., Ripley, R. Taylor

Volltext

The good, the bad, and the uncertain: Can matrix metalloproteinase 12 simultaneously be protumorigenic and antitumorigenic? von Diggs, Laurence P., Ripley, R. Taylor

Volltext

Minority MOMP: a toxic, slow demise von Xu, Yuan, Surman, Deborah R., Ripley, R. Taylor

Volltext

Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune Microenvironment von Jang, Hee-Jin, Lee, Hyun-Sung, Yu, Wendong, Ramineni, Maheshwari, Truong, Cynthia Y, Ramos, Daniela, Splawn, Taylor, Choi, Jong Min, Jung, Sung Yun, Lee, Ju-Seog, Wang, Daniel Y, Sederstrom, Joel M, Pietropaolo, Massimo, Kheradmand, Farrah, Amos, Christopher I, Wheeler, Thomas M, Ripley, R Taylor, Burt, Bryan M

Volltext

The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer von Euhus, Caleb J, Ripley, Taylor R, Medina, Cristian G

Volltext

Utilization of Minimally Invasive Thymectomy and Margin-Negative Resection for Early-Stage Thymoma von Burt, Bryan M., Nguyen, Duy, Groth, Shawn S., Palivela, Nihanth, Ripley, R. Taylor, Makris, Konstantinos I., Farjah, Farhood, Cornwell, Lorraine, Massarweh, Nader N.

Volltext

Management of Multiple Ground Glass Opacities before or after Lobectomy von Ripley, R. Taylor, Antonoff, Mara, Huang, James, Suzuki, Kenji, Gibney, Barry C.

Volltext

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma von Ripley, R. Taylor, MD, McMillan, Robert R., MD, MPH, Sima, Camelia S., MD, MS, Hasan, Saad M., BA, Ahmad, Usman, MD, Lou, Feiran, MD, Jones, David R., MD, Rusch, Valerie W., MD, Rizk, Nabil P., MD, Huang, James, MD

Volltext

Pulmonary Resection for Metastatic Adrenocortical Carcinoma: The National Cancer Institute Experience von Kemp, Clinton D., MD, Ripley, R. Taylor, MD, Mathur, Aarti, MD, Steinberg, Seth M., PhD, Nguyen, Dao M., MD, Fojo, Tito, MD, PhD, Schrump, David S., MD, MBA

Volltext

Commentary: Interleukin 2: The gasoline that lit the immunotherapeutic fire von Ripley, R. Taylor

Volltext

Trends in Major Gastrectomy for Cancer: Frequency and Outcomes von Groh, Eric M., Hyun, Noorie, Check, David, Heller, Theo, Ripley, R. Taylor, Hernandez, Jonathan M., Graubard, Barry I., Davis, Jeremy L.

Volltext

Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy von Taylor Ripley, R, Surman, Deborah R, Diggs, Laurence P, Trepel, Jane B, Lee, Min-Jung, Ryan, Jeremy, Davis, Jeremy L, Steinberg, Seth M, Hernandez, Jonathan M, Hoang, Choung, Kenney, Cara M, Bond, Colleen D, Kunst, Tricia F, Letai, Anthony, Schrump, David S

Volltext

Commentary: Drawing the target after shooting the arrow: The importance of trial design von Ripley, R. Taylor

Volltext

Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer von van Beek, Elke J. A. H., Hernandez, Jonathan M., Goldman, Debra A., Davis, Jeremy L., McLaughlin, Kaitlin, Ripley, R. Taylor, Kim, Teresa S., Tang, Laura H., Hechtman, Jaclyn F., Zheng, Jian, Capanu, Marinela, Schultz, Nikolaus, Hyman, David M., Ladanyi, Marc, Berger, Michael F., Solit, David B., Janjigian, Yelena Y., Strong, Vivian E.

Volltext

Commentary: Filling up my truck from an oil tanker: Can big ‘omic’ data influence our clinical decisions? von Ripley, R. Taylor

Volltext